1.
Piguet V, Blauvelt A, Burge D, Peterson L, Drew J, Rolleri R, Weglowska J. Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from an Ongoing Phase 3, Multicenter, Randomized, Active- and Placebo-Controlled Study (CIMPACT). J of Skin [Internet]. 2017Oct.27 [cited 2022Jul.7];1(3.1):s3. Available from: https://www.jofskin.org/index.php/skin/article/view/124